Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia.
Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.
Mater Misericordiae Ltd (MML) is seeking volunteers to join the Human Research Ethics Committee (HREC).